Recombinant Hepatitis C Virus NS5a protein

Supplementary information

This supplementary information is collated from multiple sources and compiled automatically.

The Hepatitis C Virus NS5a (HCV NS5a) protein often simply referred to as NS5a protein is a non-structural protein important in the hepatitis C virus lifecycle. This phosphoprotein weighs approximately 56 kilodaltons and shows its expression primarily in hepatocytes cells in the liver. Researchers target NS5a as a pivotal modulator in the replication of HCV RNA and its role has made it a main target in antiviral drug development. Renowned for participating in RNA binding and interaction with other viral and host proteins NS5a supports the virus's ability to produce infectious particles making it a focus of antiviral research.

Biological function summary

NS5a plays a multifactorial role acting as part of a larger replication complex involved in HCV replication. It interacts with cellular membranes creating a replication platform for the viral RNA synthesis. Beyond its mechanical functions NS5a influences cellular pathways pivotal in the virus's persistence by modulating host cell signaling lipid metabolism and the immune response. There is active research into how NS5a manipulates host cell responses to establish chronic infection a characteristic aspect of HCV.

Pathways

NS5a significantly influences viral replication and assembly pathways. It interacts with host proteins such as cyclophilin A which regulates replication and lipid droplets important for virus assembly. The protein is integral to the PI3K-Akt pathway which NS5a manipulates to support enhanced viral RNA replication. Through its interactions NS5a links with other HCV proteins like NS3 and NS4a modulating both viral and host processes to facilitate hepatitis C virus survival and replication.

NS5a holds a direct relationship with chronic Hepatitis C infection leading to liver cirrhosis and hepatocellular carcinoma (HCC). Its ability to evade the host immune response and promote viral persistence makes it pivotal in disease progression. In the context of HCC NS5a influences the expression and activity of cellular proteins like p53 critical in cell cycle regulation. Research targets NS5a in therapeutic strategies to halt disease progression and improve patient outcomes in HCV-related liver disease.